, Volume 13, Issue 6, pp 677–686

Socioeconomics of a Global Leprosy Eradication Programme

  • Sharad S. Naik
  • Ramaswamy Ganapati
Review Article Global Leprosy Eradication Programme


In the absence of evidence in the literature on cost factors in the management of leprosy, a reference is made to the sporadic attempts to study costs of case detection and treatment. Such studies indicate that in the currently declining phase of leprosy endemicity, employing a conventionally trained, salaried class of paramedical staff for field surveys is prohibitively expensive if cost per case detected is computed. Involving primary healthcare and community derived workers is cost effective. Likewise, short course chemotherapy with newer drugs under trial, administered under supervision by community volunteers, reduces the expenses considerably. Community-based disability services using inexpensive tools may cut costs by 90%. Operational research on cost effectiveness of rehabilitation comparing ‘integrated’ with ‘vertical’ approaches is, unfortunately, still in a primitive stage.

It is urged that in view of the changing logistics, manpower costs and financial implications should be given serious consideration by health planners. Postelimination problems such as: (i) unearthing hidden cases; (ii) community-based supervised treatment with highly promising newer drugs; (iii) identification of reactions and relapses; and (iv) field management of disabilities resulting from acute and silent neuritis etc could be solved in a much cheaper manner. Integration of leprosy into general healthcare services and community-based rehabilitation of leprosy patients along with those disabled by other diseases will be the major task in future as these procedures are expected to reduce management costs and eliminate stigma.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Hansen GA. Spedalskhedens arsager (cause of leprosy). Int J Lepr 1955; 23: 307–9Google Scholar
  2. 2.
    World Health Organization (WHO). Leprosy disabilities: magnitude of the problem. Weekly epidemiological record. Geneva: WHO, 1995; 70: 269–76Google Scholar
  3. 3.
    Faget GM. Chemotherapy of leprosy. Int J Lepr 1947; 15: 7–14PubMedGoogle Scholar
  4. 4.
    Shepard CC. The experimental disease that follows the injection of human leprosy bacilli into footpad of mice. J Exp Med 1960; 112: 445–54PubMedCrossRefGoogle Scholar
  5. 5.
    Pearson JMH. Sulphone resistance in leprosy: a review of 100 proven clinical cases. Lancet 1975; II: 69–72CrossRefGoogle Scholar
  6. 6.
    Indian Association of Leprologists. Workshop on problems and perspectives in elimination of leprosy; 7 Dec 1996, RudrapurGoogle Scholar
  7. 7.
    Damien Foundation India Trust. Workshop on developing strategies for reaching urban patients; 18 Dec 1996, MadrasGoogle Scholar
  8. 8.
    World Health Organization (WHO). Progress towards elimination of leprosy as a public health problem: weekly epidemiological record. Geneva: WHO, 1996; 71: 149–56Google Scholar
  9. 9.
    World Health Organization (WHO). Tropical disease research news. Geneva: WHO, 1991: 636Google Scholar
  10. 10.
    Narayanaswamy PS, Pai VV, Ganapati R. Leprosy elimination: at what cost? Studies on leprosy: Bombay leprosy project. Vol. III. In pressGoogle Scholar
  11. 11.
    Kathe VJ, Naik SS. The participation of NSS students in leprosy eradication programme for last 7 years in Bombay. Indian J Lepr 1996; 68: 261–2PubMedGoogle Scholar
  12. 12.
    Revanker CR, Bulchand HO, Kalpana C, et al. Leprosy elimination campaign in a metropolitan leprosy project. Studies on leprosy: Bombay leprosy project. Vol. III. In pressGoogle Scholar
  13. 13.
    Ganapati R, Revankar CR, Bandkar KR, et al. Leprosy detection through non-survey techniques. Indian J Lepr 1984; 56: 622–5PubMedGoogle Scholar
  14. 14.
    Ganapati R, Revankar CR, Pai RR. Three years assessment of multidrug therapy in multibacillary leprosy cases. Indian J Lepr 1987; 59: 44–9PubMedGoogle Scholar
  15. 15.
    Rao PS, Reddy BN, Krishnamurthy P, et al. Initial intensive therapy for multibacillary leprosy patients: in retrospect. Lepr Rev 1992; 63: 355–6Google Scholar
  16. 16.
    World, Health Organization (WHO). Action programme for the elimination of leprosy. Geneva: WHO, 1996Google Scholar
  17. 17.
    World Health Organization (WHO) 7th Expert Committee (1997). WHO technical report. In pressGoogle Scholar
  18. 18.
    Ganapati R, Shroff HJ, Gandewar KL, et al. Five year follow-up of multibacillary leprosy patients after fixed duration chemotherapy. Proceedings of the Sixth Symposium on Leprosy Research; 1990 Oct 3-7; Genoa, 223–9Google Scholar
  19. 19.
    World Health Organization (WHO). Technical report series 847. Geneva: WHO, 1994Google Scholar
  20. 20.
    Kingsley S, Pai VV, Ganapati R. Disability management—how expensive? Studies on leprosy: Bombay leprosy project. Vol III. In pressGoogle Scholar
  21. 21.
    World Health Organization (WHO). A guide to eliminate leprosy as a public health problem. Pocket ed. Geneva: WHO, 1996: 71Google Scholar
  22. 22.
    Ganapati R. Leprosy: a glimpse at the changing scenario. Bombay: ALH, RRE Society and Bombay Leprosy Project, 1996: 51–2Google Scholar
  23. 23.
    Ganapati R, Narayanaswamy P, Prasad SN, et al. Can NGOs effect savings for the donor? Bombay: Bombay Leprosy Project, 1996: 5Google Scholar
  24. 24.
    Kartikeyan S, Chaturvedi RM. Pattern of leprosy deformities among agricultural labourers in an endemic district: a pilot study. Indian J Lepr 1992; 64: 375–9PubMedGoogle Scholar
  25. 25.
    Kuppusamy P, Richard J, Selvapandian AJ. A study of causes of unemployment among agricultural labourers affected by leprosy. Lepr India 1979; 51: 369–75PubMedGoogle Scholar
  26. 26.
    Fritchi EP. Values and limitation of surgery in leprosy. Lepr India 1976; 48: 4–7Google Scholar
  27. 27.
    World Health Organization (WHO). Technical report series 221. Geneva: WHO, 1960.Google Scholar

Copyright information

© Adis International Limited 1998

Authors and Affiliations

  • Sharad S. Naik
    • 1
  • Ramaswamy Ganapati
    • 2
  1. 1.Research, Rehabilitation and Education SocietyAcworth Municipal Leprosy HospitalWadala MumbaiIndia
  2. 2.Bombay Leprosy ProjectSion-ChunabhattiIndia

Personalised recommendations